methoxyhydroxyphenylglycol has been researched along with Clerambault Syndrome in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agartz, I; Andreou, D; Edman-Ahlbom, B; Gunnar, A; Hall, H; Jönsson, EG; Saetre, P; Sedvall, G; Sillén, A; Terenius, L | 1 |
| Anderson, GM; Caparulo, BK; Cohen, DJ; Detlor, J; Harcherik, D; Hunt, RD; Kavanagh, ME; Leckman, JF; Shaywitz, BA; Shaywitz, SE; Young, JG | 1 |
| Bryer, JB; Parikh, RM; Price, TR; Robinson, RG; Starkstein, SE; Votypka, V | 1 |
| Degrell, I; Nagy, E | 1 |
| Agren, H; Akerström, G; Hetta, J; Joborn, C; Ljunghall, S; Niklasson, F; Rastad, J; Wide, L | 1 |
| Percy, AK; Riccardi, VM; Zoghbi, H | 1 |
6 other study(ies) available for methoxyhydroxyphenylglycol and Clerambault Syndrome
| Article | Year |
|---|---|
Brain-derived neurotrophic factor gene variation influences cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol concentrations in healthy volunteers.
Topics: Adult; Brain; Brain Chemistry; Brain-Derived Neurotrophic Factor; DNA Mutational Analysis; Female; Gene Frequency; Genetic Predisposition to Disease; Genetic Testing; Genotype; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Neurocognitive Disorders; Norepinephrine; Polymorphism, Genetic; Predictive Value of Tests; Serotonin; Young Adult | 2008 |
Assessment of brain function in clinical pediatric research: behavioral and biological strategies.
Topics: Catecholamines; Child; Child Behavior Disorders; Developmental Disabilities; Ethics, Medical; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Informed Consent; Interview, Psychological; Methoxyhydroxyphenylglycol; Motor Skills; Neurocognitive Disorders; Perception; Psychological Tests; Research | 1982 |
Reduction of CSF monoamine metabolites in poststroke depression: a preliminary report.
Topics: Adult; Aged; Cerebral Infarction; Depressive Disorder; Dominance, Cerebral; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neurocognitive Disorders | 1992 |
Correlations between cisternal CSF and plasma concentrations of HVA, MHPG, 5-HIAA, DA, and NA.
Topics: Adult; Aged; Aged, 80 and over; Blood-Brain Barrier; Brain; Brain Diseases; Dopamine; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neurocognitive Disorders; Norepinephrine | 1990 |
Cerebrospinal fluid calcium, parathyroid hormone, and monoamine and purine metabolites and the blood-brain barrier function in primary hyperparathyroidism.
Topics: Blood-Brain Barrier; Calcium; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Hyperparathyroidism; Hypoxanthine; Hypoxanthines; Methoxyhydroxyphenylglycol; Neurocognitive Disorders; Parathyroid Glands; Parathyroid Hormone; Serum Albumin; Xanthine; Xanthines | 1991 |
Rett syndrome: initial experience with an emerging clinical entity.
Topics: Adolescent; Biopsy; Child; Child Development; Child, Preschool; Electroencephalography; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Intellectual Disability; Methoxyhydroxyphenylglycol; Neurocognitive Disorders; Psychomotor Performance; Stereotyped Behavior; Sural Nerve; Syndrome | 1985 |